PubMed COVID-19 Clinical Care

COVID-19 is a relatively new disease whose complete pathogenesis and complications have not been elucidated. Apart from the morbidity and mortality caused by the virus itself, it is noted that patients affected with this virus have a higher

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces B and T cell responses, contributing to virus neutralization. In a cohort of 2,911 young adults, we identified 65 individuals who had an asymptomatic or mildly symptomatic SARS

No abstract

A method is developed to electrochemically induce target-specific covalent capturing of the spike protein of SARS-Cov-2, forming a covalent peptide-protein complex fit for working with such complicated clinical samples. Specifically, peptide

CONCLUSIONS: Such promising results demonstrate that the Monkey-CAD can be employed to assist health practitioners. They also verify that fusing deep features from selected CNNs can boost performance.

How to develop highly informative serology assays to evaluate the quality of immune protection against coronavirus disease-19 (COVID-19) has been a global pursuit over the past years. Here, a microfluidic high-plex immuno-serolomic assay is developed

CONCLUSIONS: Failure of officials to consider the insights of mindful planning efforts resulted in mindless reactions. These results highlight how vital it is for organizations dealing with high-risk public health issues to follow a mindful approach

CONCLUSION: Informal caregivers are faced with worse mental health than non-caregivers during the pandemic, although their social support was stronger, in particular in dependence of higher levels of perceived restrictions by the pandemic. Thus

ICBS 2022 was a refreshing multi-day event where it was justified that the advancement of chemical biology did not halt due to the pandemic, but in contrast, amazing findings were discovered within the restrictions of the SARS-CoV-2 pandemic. All

No abstract